Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Rapid Micro Biosystems Q3 2023 EPS $(0.31), Inline, Sales $6.14M Beat $5.55M Estimate

Author: Benzinga Newsdesk | November 03, 2023 07:02am
Rapid Micro Biosystems (NASDAQ:RPID) reported quarterly losses of $(0.31) per share which met the analyst consensus estimate. This is a 18.42 percent increase over losses of $(0.38) per share from the same period last year. The company reported quarterly sales of $6.14 million which beat the analyst consensus estimate of $5.55 million by 10.72 percent. This is a 29.67 percent increase over sales of $4.74 million the same period last year.

Posted In: RPID


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist